CD44 and carcinoma: As more than one subtype of CSCs may co-exist in the same tumor, there is also a possibility that CD44 positivity mainly characterizes the terminally differentiated tumor cells, which retain their specialized function. Other authors have hypothesized that the reduced expression of CD44 in poorly differentiated carcinomas may reflect loss of extracellular adhesion and increased invasive potential [22].